Assertio Therapeutics
在场
高管
查看带有其 13 名主要高管的组织结构图
Assertio Therapeutics 搜索最多的简介
高管在Assertio Therapeutics变化
- Peter Staple, Chairman of the Board, 已经离开公司 (新闻发布的2024七月26号).
- William McKee, Director, 已经离开公司 (新闻发布的2024七月26号).
- Heather Mason, Director, 已经离开公司 (新闻发布的2024七月26号).
创建提醒
跟踪 Assertio Therapeutics 的高管变动
药店
Assertio Therapeutics 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
药店 行业的其他推荐联系人
消息
Assertio Therapeutics 的最新新闻稿
- Assertio Reports Third Quarter 2024 Financial Results
- Assertio Provides Response to Letter from Short-seller
- Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
- Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
- Assertio Reports Second Quarter 2024 Financial Results
- Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
- View more press releases Close
通过电子邮件
